Last reviewed · How we verify
Autologous Regulatory Т-cells
At a glance
| Generic name | Autologous Regulatory Т-cells |
|---|---|
| Sponsor | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: